Summit Therapeutics Inc. Other Comprehensive Income Net Of Tax Exchange Differences On Translation
Summit Therapeutics Inc. (SMMT) reported Other Comprehensive Income Net Of Tax Exchange Differences On Translation of GBP 13.00 thousand for the 3-month period ending 2020-03-31, per its 6-K filed 2020-06-02.
Discontinued › Income Statement › Unrealized Gains
ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation · last filed 2020-06-02
- Summit Therapeutics Inc. other comprehensive income net of tax exchange differences on translation for the quarter ending 2020-03-31 was 13.00K GBP.
- Summit Therapeutics Inc. other comprehensive income net of tax exchange differences on translation for the quarter ending 2019-03-31 was -6.00K GBP.
| Period end | Other Comprehensive Income Net Of Tax Exchange Differences On Translation 3 month | Other Comprehensive Income Net Of Tax Exchange Differences On Translation 11 month | Other Comprehensive Income Net Of Tax Exchange Differences On Translation 12 month |
|---|---|---|---|
| 2020-03-31 | 13.00K GBP 6-K · filed 2020-06-02 | ||
| 2019-12-31 | 0.00 GBP 20-F · filed 2020-04-30 | ||
| 2019-03-31 | -6.00K GBP 6-K · filed 2020-06-02 | ||
| 2019-01-31 | 19.00K GBP 20-F · filed 2020-04-30 | ||
| 2018-01-31 | -13.00K GBP 20-F · filed 2020-04-30 | ||
| 2017-01-31 | 29.00K GBP 20-F · filed 2019-03-29 | ||
| 2016-01-31 | -41.00K GBP 20-F · filed 2018-04-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |